S. Kaubitzsch

A phase I study of  EpCAM/CD3-bispecific antibody (MT110) in patients with advanced solid tumors.

Walter Fiedler, M. Wolf, Maxim Kebenko et al. · Journal of Clinical Oncology · 2012 · 36 citations

Medicine, Oncology, Pharmacology +17

Topotecan - A New Treatment Option in the Therapy of Brain Metastases of Lung Cancer

W. Sch�tte, C. Manegold, Joachim von Pawel et al. · Frontiers of radiation therapy and oncology · 1999 · 34 citations

Medicine, Oncology, Pharmacology +12

Phase I safety and pharmacology study of the EpCAM/CD3-bispecific BiTE antibody MT110 in patients with metastatic colorectal, gastric, or lung cancer.

Walter Fiedler, Birgit Ritter, Ruth Seggewiss et al. · Journal of Clinical Oncology · 2010 · 23 citations

Medicine, Oncology, Pharmacology +17

Long time therapy with topotecan in patients with recurrence of ovarian carcinoma.

Möbus, Pfaff Pn, T. Volm et al. · PubMed · 2002 · 17 citations

Pharmacy, Oncology, Pharmacotherapy +16

Dose Finding Study for Combination Treatment with Topotecan and Gemcitabine of Patients with Recurrent Ovarian Cancer after Failure of First-Line Chemotherapy with Paclitaxel and Platinum

Jalid Sehouli, Dirk Stengel, G. Oskay et al. · Oncology Research and Treatment · 2004 · 12 citations

Medicine, Oncology, Pharmacology +17